CTS Research Consortium was established to further CTS’s leadership in infectious disease research. This collaboration between Vitalant Research Institute, Carter BloodCare, OneBlood, ITxM, New York Blood Center and Bloodworks Northwest will provide a wealth of data for the development of future hypothesis-based research studies.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.